EP0000338A3 - Isoxazolo(5,4-c)pyridine derivatives, their preparation and pharmaceutical compositions containing them - Google Patents
Isoxazolo(5,4-c)pyridine derivatives, their preparation and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- EP0000338A3 EP0000338A3 EP78100191A EP78100191A EP0000338A3 EP 0000338 A3 EP0000338 A3 EP 0000338A3 EP 78100191 A EP78100191 A EP 78100191A EP 78100191 A EP78100191 A EP 78100191A EP 0000338 A3 EP0000338 A3 EP 0000338A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- isoxazolo
- preparation
- pharmaceutical compositions
- compositions containing
- pyridine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2574077 | 1977-06-20 | ||
GB2574077 | 1977-06-20 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP80106498.1 Division-Into | 1980-10-23 | ||
EP80106497.3 Division-Into | 1980-10-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0000338A2 EP0000338A2 (en) | 1979-01-24 |
EP0000338A3 true EP0000338A3 (en) | 1979-06-27 |
EP0000338B1 EP0000338B1 (en) | 1981-11-25 |
Family
ID=10232513
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP78100190A Withdrawn EP0000167A1 (en) | 1977-06-20 | 1978-06-19 | 1,2,3,6-Tetrahydroisonicotinic acid and derivatives thereof, methods and starting products for their preparation, and pharmaceutical compositions containing them. |
EP80106497A Withdrawn EP0027279A1 (en) | 1977-06-20 | 1978-06-19 | Isoxazolo(5,4-C)pyridines |
EP80106498A Withdrawn EP0028017A1 (en) | 1977-06-20 | 1978-06-19 | 3-Piperidinone-4-carboxylic acid derivatives |
EP78100191A Expired EP0000338B1 (en) | 1977-06-20 | 1978-06-19 | Isoxazolo(5,4-c)pyridine derivatives, their preparation and pharmaceutical compositions containing them |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP78100190A Withdrawn EP0000167A1 (en) | 1977-06-20 | 1978-06-19 | 1,2,3,6-Tetrahydroisonicotinic acid and derivatives thereof, methods and starting products for their preparation, and pharmaceutical compositions containing them. |
EP80106497A Withdrawn EP0027279A1 (en) | 1977-06-20 | 1978-06-19 | Isoxazolo(5,4-C)pyridines |
EP80106498A Withdrawn EP0028017A1 (en) | 1977-06-20 | 1978-06-19 | 3-Piperidinone-4-carboxylic acid derivatives |
Country Status (14)
Country | Link |
---|---|
US (2) | US4278676A (en) |
EP (4) | EP0000167A1 (en) |
JP (2) | JPS5436290A (en) |
AT (1) | AT368505B (en) |
AU (2) | AU3724478A (en) |
CA (1) | CA1107736A (en) |
DK (2) | DK270378A (en) |
ES (2) | ES470912A1 (en) |
FI (2) | FI64376C (en) |
IE (1) | IE47200B1 (en) |
IT (2) | IT7868449A0 (en) |
NO (3) | NO152049C (en) |
NZ (1) | NZ187615A (en) |
ZA (2) | ZA783493B (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3145473A1 (en) * | 1980-11-27 | 1982-08-26 | Kefalas A/S, Koebenhavn-Valby | 2-Substituted 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-one compounds, processs for their preparation and medicaments containing them |
DE3145474A1 (en) * | 1980-11-27 | 1982-09-02 | Kefalas A/S, Koebenhavn-Valby | 3-Substituted 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine compounds, process for their preparation and medicaments containing them |
EP0083378A1 (en) * | 1981-12-22 | 1983-07-13 | Chugai Seiyaku Kabushiki Kaisha | Tetrahydronicotinamide derivatives, a process for producing the same and a pharmaceutical composition comprising the same |
GB8314391D0 (en) * | 1983-05-24 | 1983-06-29 | Kefalas As | Heterocyclic compounds |
IT1228426B (en) * | 1987-07-20 | 1991-06-17 | Ausimont Spa | HETEROCYCLIC PEROXIDE |
US4859666A (en) * | 1988-07-06 | 1989-08-22 | Bristol-Myers Company | THAZ derivatives for enhancement of cerebral function |
CN1043051C (en) * | 1994-07-22 | 1999-04-21 | 国际壳牌研究有限公司 | Process for producing a hydrowax |
EP2145620A3 (en) | 2003-06-25 | 2010-03-17 | H. Lundbeck A/S | Gaboxadol for treating depression and other affective disorders |
US20050234093A1 (en) * | 2003-06-25 | 2005-10-20 | H. Lundbeck A/S | Treatment of depression and other affective disorders |
AR045540A1 (en) * | 2003-09-05 | 2005-11-02 | Lundbeck & Co As H | METHOD OF ELABORATION OF 4,5,6,7 TETRAHYDROISOXAZOL [5,4-C] PIRIDIN-3-OL (THIP) |
PT1691811E (en) * | 2003-12-11 | 2014-10-30 | Sunovion Pharmaceuticals Inc | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
US20050137222A1 (en) * | 2003-12-18 | 2005-06-23 | H. Lundbeck A/S | Treatment of insomnia in human patients |
US20050215521A1 (en) * | 2003-12-22 | 2005-09-29 | Karim Lalji | Modafinil combination therapy for improving sleep quality |
AU2004308962A1 (en) * | 2003-12-24 | 2005-07-14 | Sepracor Inc. | Melatonin combination therapy for improving sleep quality |
GB0402118D0 (en) * | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
WO2005079851A2 (en) * | 2004-02-18 | 2005-09-01 | Sepracor, Inc. | Dopamine-agonist combination therapy with sedatives for improving sleep quality |
GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
EP2292222A1 (en) | 2005-01-28 | 2011-03-09 | H. Lundbeck A/S | Polymorphic Forms of a GABAA Agonist |
US20080262029A1 (en) * | 2005-04-29 | 2008-10-23 | H. Lundbeck A/S | Acid and Base Salt Forms of Gaboxadol |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
JP2009512711A (en) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Regulation of neurogenesis by PDE inhibition |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20070203216A1 (en) * | 2006-02-14 | 2007-08-30 | Bjarke Ebert | Method of treating inflammatory diseases |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
AU2007249435A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
AU2007292848A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100193652A1 (en) * | 2009-02-02 | 2010-08-05 | William Stajos | Wall Display System And Method Of Providing The Same |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US8784835B2 (en) * | 2012-07-02 | 2014-07-22 | Trent Austin | Method for producing muscimol and/or reducing ibotenic acid from amanita tissue |
CN104974175A (en) * | 2014-04-11 | 2015-10-14 | 天津药物研究院 | Preparation method of aminomethyl hydroxyisooxazole analogue |
JP2017516868A (en) | 2014-06-06 | 2017-06-22 | オービッド・セラピューティクス・インコーポレイテッドOvid Therapeutics, Inc. | How to increase persistent suppression and treat secondary insomnia |
JP6735284B2 (en) | 2015-03-24 | 2020-08-05 | ハー・ルンドベック・アクチエゼルスカベット | Production of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol |
WO2017015049A1 (en) | 2015-07-17 | 2017-01-26 | Ovid Therapeutics Inc. | Methods of treating developmental disorders with gaboxadol |
US9682069B2 (en) | 2015-07-17 | 2017-06-20 | Ovid Therapeutics Inc | Methods of treating Dravet syndrome |
US9399034B1 (en) | 2015-08-11 | 2016-07-26 | Ovid Therapeutics Inc | Methods of sedation during critical care treatment |
KR102518846B1 (en) | 2016-08-11 | 2023-04-05 | 오비드 테라퓨틱스 인크. | Methods and compositions for the treatment of epileptic disorders |
US10071083B2 (en) | 2017-02-03 | 2018-09-11 | Ovid Therapeutics Inc | Use of gaboxadol in the treatment of tinnitus |
US20180338959A1 (en) | 2017-05-24 | 2018-11-29 | Ovid Therapeutics Inc. | Treatment of depressive disorders |
CA3071939A1 (en) | 2017-08-04 | 2019-02-07 | Ovid Therapeutics Inc. | Use of gaboxadol in the treatment of diabetes and related conditions |
KR20210062662A (en) | 2018-09-20 | 2021-05-31 | 오비드 테라퓨틱스 인크. | Use of Gaboksadol for the treatment of Tourette's syndrome, ticks and stuttering |
GB2594616A (en) | 2018-11-21 | 2021-11-03 | Certego Therapeutics Inc | Gaboxadol for reducing risk of suicide and rapid relief of depression |
WO2020131856A1 (en) | 2018-12-17 | 2020-06-25 | Ovid Therapeutics Inc. | Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder |
US11597726B2 (en) | 2020-05-20 | 2023-03-07 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
CN114292224B (en) * | 2022-03-07 | 2022-05-20 | 中国农业科学院农产品加工研究所 | Cannabidiol-2- (N-acetyl) piperidine acid ester and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2784190A (en) * | 1952-03-28 | 1957-03-05 | Upjohn Co | Alkyl piperidinepropionates |
CA762455A (en) * | 1962-03-22 | 1967-07-04 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Pyrido-pyrimidines |
US3381016A (en) * | 1966-03-04 | 1968-04-30 | Upjohn Co | Isoxazolo[5, 4-b]pyridine derivatives and a method for their preparation |
DE2221770A1 (en) * | 1972-05-04 | 1973-11-15 | Bayer Ag | 1,2,5,6-tetrahydropyridines - prepd from corresp 1-benzyl tetrahydropyridines and phosgene |
DK62791A (en) * | 1991-04-09 | 1992-11-09 | Tulip Int As | PROCEDURE FOR SALTING MEAT AND PLANT FOR USE IN EXERCISE OF THE PROCEDURE |
-
1978
- 1978-06-15 DK DK270378A patent/DK270378A/en unknown
- 1978-06-15 DK DK270278A patent/DK270278A/en unknown
- 1978-06-19 ZA ZA00783493A patent/ZA783493B/en unknown
- 1978-06-19 EP EP78100190A patent/EP0000167A1/en not_active Withdrawn
- 1978-06-19 ES ES470912A patent/ES470912A1/en not_active Expired
- 1978-06-19 EP EP80106497A patent/EP0027279A1/en not_active Withdrawn
- 1978-06-19 FI FI781954A patent/FI64376C/en not_active IP Right Cessation
- 1978-06-19 NO NO782127A patent/NO152049C/en unknown
- 1978-06-19 NO NO782128A patent/NO782128L/en unknown
- 1978-06-19 ZA ZA00783492A patent/ZA783492B/en unknown
- 1978-06-19 ES ES470913A patent/ES470913A1/en not_active Expired
- 1978-06-19 IE IE1234/78A patent/IE47200B1/en unknown
- 1978-06-19 NZ NZ187615A patent/NZ187615A/en unknown
- 1978-06-19 US US05/917,118 patent/US4278676A/en not_active Expired - Lifetime
- 1978-06-19 EP EP80106498A patent/EP0028017A1/en not_active Withdrawn
- 1978-06-19 EP EP78100191A patent/EP0000338B1/en not_active Expired
- 1978-06-19 FI FI781955A patent/FI781955A/en not_active Application Discontinuation
- 1978-06-19 AU AU37244/78A patent/AU3724478A/en active Pending
- 1978-06-20 AT AT0448678A patent/AT368505B/en not_active IP Right Cessation
- 1978-06-20 JP JP7480078A patent/JPS5436290A/en active Pending
- 1978-06-20 IT IT7868449A patent/IT7868449A0/en unknown
- 1978-06-20 IT IT68450/78A patent/IT1159739B/en active
- 1978-06-20 JP JP7479978A patent/JPS5436275A/en active Pending
- 1978-06-20 AU AU37298/78A patent/AU521040B2/en not_active Expired
- 1978-06-20 CA CA305,798A patent/CA1107736A/en not_active Expired
-
1979
- 1979-09-03 NO NO792839A patent/NO792839L/en unknown
- 1979-12-17 US US06/104,080 patent/US4301287A/en not_active Expired - Lifetime
Non-Patent Citations (4)
Title |
---|
ACTA CHEMICA SCANDINAVICA B28, Pages 533-38 (1974) * |
CHEMICAL ABSTRACTS 84, 159505z (1976) * |
CHEMICAL ABSTRACTS 88, 37672p (1978) & Acta Chemica Scandinavica B31 (7), 584-8 (1977) * |
NATUR (London) 268 (5615) 53-5 (1977) * |
Also Published As
Publication number | Publication date |
---|---|
JPS5436290A (en) | 1979-03-16 |
IE47200B1 (en) | 1984-01-11 |
NO152049C (en) | 1985-07-24 |
EP0000338A2 (en) | 1979-01-24 |
AU3729878A (en) | 1980-01-03 |
DK270378A (en) | 1978-12-21 |
FI781955A (en) | 1978-12-21 |
IT7868450A0 (en) | 1978-06-20 |
IT7868449A0 (en) | 1978-06-20 |
ES470912A1 (en) | 1979-02-01 |
FI64376B (en) | 1983-07-29 |
IT1159739B (en) | 1987-03-04 |
JPS5436275A (en) | 1979-03-16 |
EP0027279A1 (en) | 1981-04-22 |
CA1107736A (en) | 1981-08-25 |
ZA783493B (en) | 1979-06-27 |
US4278676A (en) | 1981-07-14 |
NO782128L (en) | 1978-12-21 |
ES470913A1 (en) | 1979-02-01 |
NZ187615A (en) | 1981-12-15 |
EP0028017A1 (en) | 1981-05-06 |
ATA448678A (en) | 1982-02-15 |
NO792839L (en) | 1978-12-21 |
FI64376C (en) | 1983-11-10 |
AU521040B2 (en) | 1982-03-11 |
US4301287A (en) | 1981-11-17 |
AT368505B (en) | 1982-10-25 |
IE781234L (en) | 1978-12-20 |
EP0000167A1 (en) | 1979-01-10 |
FI781954A (en) | 1978-12-21 |
NO782127L (en) | 1978-12-21 |
NO152049B (en) | 1985-04-15 |
DK270278A (en) | 1978-12-21 |
ZA783492B (en) | 1979-06-27 |
AU3724478A (en) | 1980-01-03 |
EP0000338B1 (en) | 1981-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0000338A3 (en) | Isoxazolo(5,4-c)pyridine derivatives, their preparation and pharmaceutical compositions containing them | |
DE2861316D1 (en) | Thienothiazine derivatives, their preparation and compositions containing them | |
IL56206A0 (en) | New 1,2-benzothiazine-1,1-doxide derivatives, their preparation and pharmaceutical compositions containing them | |
IL54842A (en) | 1-piperidino-phthalazine derivatives,their preparation and pharmaceutical compositions containing them | |
IL49702A (en) | Thieno(2,3-c)pyridine derivatives, their preparation and pharmaceutical compositions containing them | |
IL49405A (en) | Substitutet 4,5,6,7-tetrahydrothieno(i8o-c)(or(o8i-c)pyridinol derivatives, their preparation and therapeutic compositions containing them | |
IL56155A (en) | Substituted alkanoylanilide derivatives,their preparation and pharmaceutical compositions comprising them | |
IL55906A0 (en) | Novel erythromycine derivatives,their preparation and phararmaceutical compositions containing them | |
IL64759A0 (en) | Furo-(3,4-c)pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
IL55770A (en) | 4-phenyl-2-acylaminothiazole derivatives,their preparation and immunostimulant compositions containing them | |
IL55242A0 (en) | Novel pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
IL54519A0 (en) | 2-diarylalkyl-1-azabicyclo (2,2,2) octanes, their preparation and pharmaceutical compositions containing them | |
IL55765A (en) | Dehydropyridine derivatives,their preparation and pharmaceutical compositions containing them | |
IL52997A (en) | 6-substituted-3-amino-4-phenyl-1h-pyrazolo(3,4-b)pyridine derivatives, their preparation and pharmaceutical compositions containing them | |
IL54535A0 (en) | Novel -lactam derivatives, their preparation and pharmaceutical compositions containing them | |
IL53857A0 (en) | New aminoalkoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them | |
IL55813A0 (en) | Movel triazile derivatives, their preparation and pharmaceutical compositions containing them | |
IL54814A (en) | 5,11-dihydro-11(piperazin-1-yl-alkanoyl)-6h-pyrido(2,3-b) (1,4)benzoidiazepin-6-one derivatives,their preparation and pharmaceutical compositions containing them | |
IL61614A (en) | Ergoline derivatives,their preparation and pharmaceutical compositions containing them | |
IL54287A0 (en) | New thienopyridine derivatives, their preparation and pharmaceutical compositions containing them | |
IL55894A (en) | 1-alkylenedithia (or oxathia) benzyl-4-heteroaryl-piperazine derivatives,their preparation and pharmaceutical compositions containing them | |
IL54547A0 (en) | Novel pyridazinone derivatives, their preparation and pharmaceutical compositions containing them | |
IL53766A0 (en) | 4-diphenylmethylene-1-hydroxybenzyl-piperidine derivatives, their preparation and pharmaceutical compositions containing them | |
IL55857A (en) | Benzodioxanylcarbonyl-piperazinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them | |
IL54328A (en) | Substituted pyrido(2,1-b)quinazoline-11-one derivatives,their manufacture and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
17P | Request for examination filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
REF | Corresponds to: |
Ref document number: 2861342 Country of ref document: DE Date of ref document: 19820128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19820630 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19830609 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19840612 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19840629 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19840630 Year of fee payment: 7 Ref country code: BE Payment date: 19840630 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19840730 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19860630 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19870620 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Effective date: 19870630 |
|
BERE | Be: lapsed |
Owner name: H. LUNDBECK & CO. A/S Effective date: 19870630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19880101 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19880226 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19880301 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19881117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Effective date: 19890630 |
|
EUG | Se: european patent has lapsed |
Ref document number: 78100191.2 Effective date: 19880711 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |